Skip to main navigation
Skip to main content
Skip to Footer
Google Tag Manager
Navigate Novartis
Patients
Healthcare Professionals
Media
Investors
Partners
ESG
Job Seekers
Clinical Trials
Coronavirus
Global
Novartis site directory
Our Company
Our Leadership
Board of Directors
Executive Committee of Novartis
Our Approach
Strategy
Corporate Responsibility
Diversity & Inclusion
Partnering
Novartis and the European Union
People and Culture
Our Business
Global Product Portfolio
Innovative Medicines
Novartis Pharmaceuticals
Novartis Gene Therapies
Novartis Oncology
Sandoz
Media
Newsroom
News Archive
Multimedia Resources
Subscribe to Updates
Investors
Event Calendar
Financial Data
Share Data & Analysis
Shareholder Information
Environmental, Social & Governance
Our Focus
Disease Areas
Cancer
Cardiovascular, Renal and Metabolic Medicine
Immunology & Dermatology
Ophthalmology
Neuroscience
Respiratory
Platforms and Technology
Data and Digital
Cell & Gene Therapy
Novartis Stories
Discovery
From Our Labs
Access to Healthcare
Patient Perspectives
People and Culture
Live Magazine
Our Impact
Building Trust with Society
Corporate Responsibility
Ethical Standards
Access
Environmental Sustainability
Global Health
Malaria
Sickle Cell Disease
Chagas disease
Leprosy
Novartis Foundation
ESG Performance and Reporting
Materiality Assessment
Environmental, Social and Governance
Transparency and Disclosures
Positions on Key Topics
Statements on Key Issues
Our Science
Research & Early Development
Novartis Institutes for BioMedical Research
Research Disease Areas
Postdoc Program
Open Source Science
Drug Development at Novartis
Novartis Pipeline
Clinical Trials
Translational Medicine
Global Product Portfolio
Science Stories
Discovery
From Our Labs
Careers
Your Career
Global Career Search
Teams and Skills
Gene Therapies Careers
Ethics, Risk & Compliance (ERC)
Working at Novartis
Diversity & Inclusion
People and Culture
Corporate Responsibility
Career Programs
Our Career Programs
Students and Scholars
Novartis Quantitative Sciences Hackathon
Search
Cancer Research Institute
View All Stories
Patient Perspectives
Choosing the right care
Discovery
Saving tumor suppressors from the shredder
Discovery
Eyewitness to a healer pursues new treatments for patients
Discovery
Reaping cancer clues from the blood
Discovery
Talking to: Bruno Strigini on why we're entering a transformative time in cancer care
Contains Video
Discovery
How scientists aim to expand immunotherapy options for cancer patients
From Our Labs
CRISPR genome editing fuels cancer drug discovery
Discovery
Intractable tumor cells crippled
Contains Video
Discovery
Novartis cancer researchers advance precision medicine
From Our Labs
Cancer spies find drug-beating covert cells
Search Results Navigation
Current page
1
of 2
Page
2
of 2
Next page
next ›
Last page
last »
